Drug Profile
DC070 547
Alternative Names: DC070-547Latest Information Update: 28 May 2021
Price :
$50
*
At a glance
- Originator ADT Pharmaceuticals
- Class Antineoplastics; Indenes; Small molecules
- Mechanism of Action Ras protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Malignant melanoma; Non-small cell lung cancer
Most Recent Events
- 28 May 2021 No recent reports of development identified for preclinical development in Malignant-melanoma in USA
- 28 May 2021 No recent reports of development identified for preclinical development in Non-small-cell-lung-cancer in USA
- 01 Apr 2017 Preclinical trials in Malignant melanoma in USA (unspecified route) before April 2017